Product concentration
The portfolio has been narrowed to NZT-48 and a limited set of remaining products.
- Scope
- Revenue and brand dependence on one core product line
- Materiality
- high
Limitless X Holdings Inc.
Limitless X Holdings Inc. is a U.S.-based consumer products and brand licensing company centered on nutritional supplements and related wellness products. Its business has included manufacturing and distributing licensed products under agreements tied to brands controlled by its CEO, with recent disclosures showing a narrower focus on the NZT-48 supplement line after other licensed product lines were discontinued.
−961,8 %
75,3 %
−4 872,1 %
−71,8 %
0.04
0.01
| % | |
|---|---|
| Nutritional supplements | 70% Dietary and wellness supplement products sold under the company's branded and licensed portfolio. |
| Licensed consumer products | 20% Products manufactured and distributed under third-party or related-party brand licenses. |
| Royalty and licensing arrangements | 10% Revenue-linked commercialization rights and royalty economics tied to licensed brands. |
The company sells to consumers seeking nutritional and wellness products, typically through branded consumer channels...
- End consumersprimary
Buy supplements such as NZT-48 for personal wellness, convenience, and brand appeal.
- Brand licensorsprimary
Provide product rights and receive royalties; they determine which products can be sold.
- Retail and distribution channelssecondary
Purchase or carry the company's consumer products to reach final shoppers.
The available filings do not disclose a meaningful country-by-country revenue split, so the business profile is best...
- •United States is the primary operating and reporting base
- •No country-level revenue split was disclosed in the excerpts
- •Consumer product sales may be distributed through U.S. channels
- •Geographic concentration increases dependence on U.S. demand and regulation
Recent disclosures suggest a strategy of narrowing the product portfolio and concentrating on the NZT-48 supplement...
01
Focus on core supplement productsshort-term
A narrower portfolio can improve execution, inventory control, and brand focus.
02
Rationalize licensing and royalty structureshort-term
Lower complexity may reduce disputes, cash leakage, and related-party friction.
The company faces concentration risk because its product set has been narrowed and its commercial rights depend on a...
Related-party dependence
Key licenses and preferred stock holders are tied to the CEO or CEO-controlled entities.
- Scope
- Governance, pricing, and transaction fairness
- Materiality
- high
License and royalty risk
The company needs valid license rights to manufacture and distribute products.
- Scope
- Commercial rights and gross margin structure
- Materiality
- high
Consumer demand and regulatory risk
Supplement sales depend on consumer acceptance and compliance with product rules.
- Scope
- Sales volatility, recalls, and marketing restrictions
- Materiality
- medium
Revenue recognition for product sales
Affects reported sales timing and net revenue
Royalty accruals and license obligations
Affects gross margin and accrued liabilities
Inventory returns and license termination accounting
Affects inventory, receivables, and settlement gains/losses
Preferred stock dividend accruals and waivers
Affects equity, liabilities, and related-party disclosures
: 28.4.2026